ENFN

ENFUSION, INC. (ENFN) ANALYST NOTE Date: 2026-06-13 Current Price: $10.76

1. Structural Readiness

Aggressive/Pre-Breakout Entry: N/A (Current price is holding above support, but no breakout trigger has occurred) Breakout Level: Not yet defined (Pending confirmation of the structural high that defines the coil top) Current Price: $10.76 Extension: N/A (Price is within the coil range, not extended above the breakout level) ATR Context: Current ATR is 2.1% (Sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting the market is currently in a consolidation phase with limited immediate directional momentum.

2. Thesis Layer

Thesis Classification: TACTICAL / SETUP-LED Macro Thesis: None named at this date. Analysis: As of 2026-06-13, ENFN is not being analyzed through a specific secular macro lens (e.g., "AI Infrastructure Boom" or "Regulatory Arbitrage"). The investment case is strictly setup-led, relying on the quality of the technical structure (the forming coil) and the underlying business fundamentals. There is no external narrative driving the setup; the conviction must be derived entirely from the structural integrity of the price action and the company's execution of its stated medium-term guidance.

3. Business Fundamentals

Company Profile: Enfusion, Inc. operates as a provider of cloud-based software solutions for the investment management sector. Its footprint spans the United States, Europe, the Middle East, Africa, and the Asia Pacific. Product Suite: The company offers an integrated platform including:

• Portfolio Management System: Establishes an instant, comprehensive investment record with valuation and risk assessment tools for CIOs and portfolio managers.
• Order and Execution Management System (OEMS): Enables electronic transmission and management of trade orders across asset classes for traders and compliance teams.
• Accounting and General Ledger: Provides a real-time financial book of record for CFOs and operations teams.
• Analytics System: Empowers stakeholders to scrutinize portfolios over timeframes and generate customized visual reports.
• Managed Services: Technology-powered and managed services complementing the software offerings.

Financial Performance & Guidance (Source: Q3 2024 Earnings Transcript, 2024-11-04):

• Revenue Growth: The company delivered $51.2 million in revenue in Q3 2024, representing 15% year-over-year growth.
• Medium-Term Guidance: Management stated they remain on track to deliver a revenue growth rate of 20% to 22% over the 2025-2027 period.
• Full Year Guidance (2024): Management tightened full-year revenue guidance to a range of $202 million to $205 million.
• EBITDA Guidance: Management tightened EBITDA guidance to land between $41 million and $45 million.
• Back Book Growth: Management expects back book growth to contribute 3% to 5% of overall growth going forward.
• New Business Wins: The company signed Agile Investment Management, a Florida-based institutional firm with ~$660 million in AUM, to utilize Enfusion's OMS and Portfolio Workbench.

Forward Consensus (Source: Financial Spine, 2026-06-12):

• Forward consensus EPS for FY1 is $0.37163.
• Forward consensus EPS for FY2 is $0.39057.

4. Archetype and Conviction

Archetype: Growth Leader Fit Analysis: The company fits the Growth Leader archetype based on its consistent delivery of double-digit revenue growth (15% in Q3 2024) and management's explicit commitment to accelerating that growth to 20-22% through 2027. The business model is supported by a "land and expand" strategy, evidenced by the Agile Investment Management win and the expectation of 3-5% growth from back book (upsell/cross-sell). The product suite is comprehensive, covering the entire investment workflow from order entry to accounting and analytics, which supports high retention and expansion potential.

Valuation & Conviction Stack:

• Thesis Strength: Moderate. The thesis is tactical and lacks a named macro driver, relying on execution.
• Evidence Quality: High. The evidence base includes specific earnings guidance, concrete new client wins (Agile), and a clear product roadmap.
• Structural Quality: Moderate. The setup is "Forming," which is a positive structural signal but incomplete. The sub-threshold ATR (2.1%) suggests the market is currently quiet, which is typical for a forming coil but reduces immediate momentum.

5. Invalidations, Strengths, and Gaps

What Would Invalidate the Case:

• Fundamental: A miss on the 2025-2027 revenue growth guidance (20-22%) or a failure to maintain the tightened EBITDA margins.

What Would Strengthen the Case:

• Technical: A confirmed breakout above the coil top (breakout level) with volume expansion.
• Fundamental: Continued wins in the "higher value market segments" as mentioned in the 2024 transcript, or an acceleration in back book growth beyond the 3-5% expectation.

Gaps in Evidence Base:

• 2025-2026 Actuals: As of 2026-06-13, the evidence base relies heavily on the 2024 guidance and the 2026 consensus estimates. There is no specific evidence provided in the source block regarding the *actual* performance of the company in 2025 or the first half of 2026 to confirm if the "on track" status from 2024 held true.
• Margin Expansion: While EBITDA guidance is provided for 2024, there is no specific evidence in the provided block regarding the margin trajectory for 2025-2027 beyond the revenue growth rate.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management guidance of 20-22% revenue growth for 2025-2027; Q3 2024 revenue growth of 15% with tightened EBITDA guidance; new institutional win with Agile Investment Management ($660M AUM). Key risks: Technical setup is forming but not confirmed (no breakout yet); current ATR is sub-threshold (2.1%) indicating low momentum; lack of named secular thesis to drive immediate rerating. Sizing hint: Position size should be conservative given the "forming" status and sub-threshold volatility; treat as a partial conviction play pending breakout confirmation. Expected path: Price consolidates within the coil range while management executes on the 20-22% growth trajectory; a breakout occurs if momentum builds and volume increases, followed by a re-rating based on the growth guidance. Expected horizon: 3 to 6 months for the setup to resolve (breakout or invalidation).